Europe Active Pharmaceutical Ingredients (API) Market 2021-2028 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

About the Report

About the Report

Europe active pharmaceutical ingredients market was valued at USD 49.52 billion in 2021 and will grow by 7.3% annually over 2021-2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.

Highlighted with 95 tables and 69 figures, this 193-page report Europe Active Pharmaceutical Ingredients (API) Market 2021-2028 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Europe active pharmaceutical ingredients market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2028 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe active pharmaceutical ingredients market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.

Based on Synthesis, the Europe market is segmented into the following sub-markets with annual revenue (USD bn) for 2018-2028 included in each section.

Synthetic API

Branded Synthetic API

Generic Synthetic API

Biotech API by Drug Type:

Monoclonal Antibodies

Recombinant Proteins

Vaccines

Other Biotech APIs

Biotech API by Customer Base:

Innovative Biologic API

Generic Biosimilar API

Biotech API by Expression Technology:

Mammalian Expression

Microbial Expression

Yeast Expression

Insect Expression

Other Expression Technologies

HPAPI

Branded HPAPI

Generic HPAPI

Based on Manufacturing Process, the Europe market is segmented into the following sub-markets with annual revenue (USD bn) for 2018-2028 included in each section.

Captive Manufacturing

Branded Captive API

Generic Captive API

Merchant Manufacturing by Drug Type:

Branded Merchant API

Generic Merchant API

Merchant Manufacturing by Drug Synthesis:

Merchant Synthetic API

Merchant Biotech API

By Drug Type, the Europe market is segmented into the following sub-markets with annual revenue (USD bn) for 2018-2028 included in each section.

Branded Prescription Drugs

Generic Prescription Drugs

OTC Drugs

Geographically, the following national/local markets are fully investigated:

Germany

UK

France

Spain

Italy

Russia

Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For each key country, detailed analysis, and data for annual revenue (USD bn) are available for 2018-2028. The breakdown of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

AbbVie Inc.

Astrazeneca

Aurobindo Pharma Ltd.

BASF

Bayer AG

Boehringer Ingelheim

Catalent Inc.

Dr. Reddy's Laboratories

F. Hoffmann-La Roche

GlaxoSmithKline plc

Lonza Group

Lupin Limited

Merck & Co., Inc.

Mylan NV

Novartis International AG

Pfizer Inc.

Sanofi

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Products


Companies

Selected Key Players:

AbbVie Inc.

Astrazeneca

Aurobindo Pharma Ltd.

BASF

Bayer AG

Boehringer Ingelheim

Catalent Inc.

Dr. Reddy's Laboratories

F. Hoffmann-La Roche

GlaxoSmithKline plc

Lonza Group

Lupin Limited

Merck & Co., Inc.

Mylan NV

Novartis International AG

Pfizer Inc.

Sanofi

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Content

Table Of Content

1 Introduction 9

1.1 Industry Definition and Research Scope 9

1.1.1 Industry Definition 9

1.1.2 Research Scope 10

1.2 Research Methodology 13

1.2.1 Overview of Market Research Methodology 13

1.2.2 Market Assumption 14

1.2.3 Secondary Data 14

1.2.4 Primary Data 14

1.2.5 Data Filtration and Model Design 15

1.2.6 Market Size/Share Estimation 16

1.2.7 Research Limitations 17

1.3 Executive Summary 18

2 Market Overview and Dynamics 21

2.1 Market Size and Forecast 21

2.1.1 Impact of COVID-19 on World Economy 22

2.1.2 Impact of COVID-19 on the Market 24

2.2 Major Growth Drivers 31

2.3 Market Restraints and Challenges 39

2.4 Emerging Opportunities and Market Trends 42

2.5 Porter's Fiver Forces Analysis 46

3 Segmentation of Europe Market by Synthesis 50

3.1 Market Overview by Synthesis 50

3.2 Synthetic API 52

3.2.1 Branded Synthetic API 53

3.2.2 Generic Synthetic API 54

3.3 Biotech API 55

3.3.1 Biotech API by Drug Type 56

3.3.1.1 Monoclonal Antibodies 57

3.3.1.2 Recombinant Proteins 58

3.3.1.3 Vaccines 59

3.3.1.4 Other Biotech APIs 60

3.3.2 Biotech API by Category 61

3.3.2.1 Innovative Biologic API 62

3.3.2.2 Generic Biosimilar API 63

3.3.3 Biotech API by Expression Technology 64

3.3.3.1 Mammalian Expression 65

3.3.3.2 Microbial Expression 66

3.3.3.3 Yeast Expression 67

3.3.3.4 Insect Expression 68

3.3.3.5 Other Expression Technologies 69

3.4 HPAPI 70

3.4.1 Branded HPAPI 71

3.4.2 Generic HPAPI 72

4 Segmentation of Europe Market by Manufacturing Process 73

4.1 Market Overview by Manufacturing Process 73

4.2 Captive Manufacturing 75

4.2.1 Branded Captive API 76

4.2.2 Generic Captive API 77

4.3 Merchant Manufacturing 78

4.3.1 Merchant Manufacturing by Drug Type 79

4.3.1.1 Branded Merchant API 80

4.3.1.2 Generic Merchant API 81

4.3.2 Merchant Manufacturing by Drug Synthesis 82

4.3.2.1 Merchant Synthetic API 83

4.3.2.2 Merchant Biotech API 84

5 Segmentation of Europe Market by Therapeutic Application 85

5.1 Market Overview by Therapeutic Application 85

5.2 Infectious Diseases 87

5.3 Oncology 88

5.4 Ophthalmology 89

5.5 Cardiovascular Disorders 90

5.6 Central Nervous System 91

5.7 Pulmonary Disorders 92

5.8 Orthopedics 93

5.9 Other Applications 94

6 Segmentation of Europe Market by Drug Type 95

6.1 Market Overview by Drug Type 95

6.2 Branded Prescription Drugs 97

6.3 Generic Prescription Drugs 98

6.4 OTC Drugs 99

7 European Market 2021-2028 by Country 100

7.1 Overview of European Market 100

7.2 UK 103

7.3 France 105

7.4 Germany 107

7.5 Spain 109

7.6 Italy 111

7.7 Russia 113

7.8 Rest of European Market 115

8 Competitive Landscape 117

8.1 Overview of Key Vendors 117

8.2 New Product Launch, Partnership, Investment, and M&A 120

8.3 Company Profiles 121

AbbVie Inc. 121

Astrazeneca 123

Aurobindo Pharma Ltd. 128

BASF 131

Bayer AG 134

Boehringer Ingelheim 138

Catalent Inc. 143

Dr. Reddy's Laboratories 146

F. Hoffmann-La Roche 148

GlaxoSmithKline plc 150

Lonza Group 155

Lupin Limited 160

Merck & Co., Inc. 163

Mylan NV 166

Novartis International AG 169

Pfizer Inc. 172

Sanofi 177

Sun Pharmaceutical Industries Ltd. 180

Teva Pharmaceutical Industries Ltd. 183

Thermo Fisher Scientific 185

9 Investing in Europe Market: Risk Assessment and Management 187

9.1 Risk Evaluation of Europe Market 187

9.2 Critical Success Factors (CSFs) 190

Related Reports and Products 193


List Of Figure

List of Figures:

Figure 1. Research Method Flow Chart 13

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16

Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2028 18

Figure 4. Europe Active Pharmaceutical Ingredients (API) Market, 2021-2028, USD bn 21

Figure 5. Impact of COVID-19 on Business 24

Figure 6. Primary Drivers and Impact Factors of Europe Active Pharmaceutical Ingredients (API) Market 31

Figure 7. GDP per capita in the World, 1960-2018, USD thousand 34

Figure 8. Leading Causes of Death in the World, 2019-2020, million 35

Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 36

Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 36

Figure 11. Primary Restraints and Impact Factors of Europe Active Pharmaceutical Ingredients (API) Market 39

Figure 12. Investment Opportunity Analysis 43

Figure 13. Porter's Fiver Forces Analysis of Europe Active Pharmaceutical Ingredients (API) Market 46

Figure 14. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, % of Revenue 50

Figure 15. Contribution to Europe 2022-2028 Cumulative Revenue by Synthesis, Value (USD bn) and Share (%) 51

Figure 16. Europe Active Pharmaceutical Ingredients (API) Market: Synthetic API, 2018-2028, USD bn 52

Figure 17. Europe Active Pharmaceutical Ingredients (API) Market: Branded Synthetic API, 2018-2028, USD bn 53

Figure 18. Europe Active Pharmaceutical Ingredients (API) Market: Generic Synthetic API, 2018-2028, USD bn 54

Figure 19. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API, 2018-2028, USD bn 55

Figure 20. Europe Active Pharmaceutical Ingredients (API) Market: Monoclonal Antibodies, 2018-2028, USD bn 57

Figure 21. Europe Active Pharmaceutical Ingredients (API) Market: Recombinant Proteins, 2018-2028, USD bn 58

Figure 22. Europe Active Pharmaceutical Ingredients (API) Market: Vaccines, 2018-2028, USD bn 59

Figure 23. Europe Active Pharmaceutical Ingredients (API) Market: Other Biotech APIs, 2018-2028, USD bn 60

Figure 24. Europe Active Pharmaceutical Ingredients (API) Market: Innovative Biologic API, 2018-2028, USD bn 62

Figure 25. Europe Active Pharmaceutical Ingredients (API) Market: Generic Biosimilar API, 2018-2028, USD bn 63

Figure 26. Europe Active Pharmaceutical Ingredients (API) Market: Mammalian Expression, 2018-2028, USD bn 65

Figure 27. Europe Active Pharmaceutical Ingredients (API) Market: Microbial Expression, 2018-2028, USD bn 66

Figure 28. Europe Active Pharmaceutical Ingredients (API) Market: Yeast Expression, 2018-2028, USD bn 67

Figure 29. Europe Active Pharmaceutical Ingredients (API) Market: Insect Expression, 2018-2028, USD bn 68

Figure 30. Europe Active Pharmaceutical Ingredients (API) Market: Other Expression Technologies, 2018-2028, USD bn 69

Figure 31. Europe Active Pharmaceutical Ingredients (API) Market: HPAPI, 2018-2028, USD bn 70

Figure 32. Europe Active Pharmaceutical Ingredients (API) Market: Branded HPAPI, 2018-2028, USD bn 71

Figure 33. Europe Active Pharmaceutical Ingredients (API) Market: Generic HPAPI, 2018-2028, USD bn 72

Figure 34. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, % of Revenue 73

Figure 35. Contribution to Europe 2022-2028 Cumulative Revenue by Manufacturing Process, Value (USD bn) and Share (%) 74

Figure 36. Europe Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing, 2018-2028, USD bn 75

Figure 37. Europe Active Pharmaceutical Ingredients (API) Market: Branded Captive API, 2018-2028, USD bn 76

Figure 38. Europe Active Pharmaceutical Ingredients (API) Market: Generic Captive API, 2018-2028, USD bn 77

Figure 39. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing, 2018-2028, USD bn 78

Figure 40. Europe Active Pharmaceutical Ingredients (API) Market: Branded Merchant API, 2018-2028, USD bn 80

Figure 41. Europe Active Pharmaceutical Ingredients (API) Market: Generic Merchant API, 2018-2028, USD bn 81

Figure 42. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Synthetic API, 2018-2028, USD bn 83

Figure 43. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Biotech API, 2018-2028, USD bn 84

Figure 44. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, % of Revenue 85

Figure 45. Contribution to Europe 2022-2028 Cumulative Revenue by Therapeutic Application, Value (USD bn) and Share (%) 86

Figure 46. Europe Active Pharmaceutical Ingredients (API) Market: Infectious Diseases, 2018-2028, USD bn 87

Figure 47. Europe Active Pharmaceutical Ingredients (API) Market: Oncology, 2018-2028, USD bn 88

Figure 48. Europe Active Pharmaceutical Ingredients (API) Market: Ophthalmology , 2018-2028, USD bn 89

Figure 49. Europe Active Pharmaceutical Ingredients (API) Market: Cardiovascular Disorders, 2018-2028, USD bn 90

Figure 50. Europe Active Pharmaceutical Ingredients (API) Market: Central Nervous System, 2018-2028, USD bn 91

Figure 51. Europe Active Pharmaceutical Ingredients (API) Market: Pulmonary Disorders, 2018-2028, USD bn 92

Figure 52. Europe Active Pharmaceutical Ingredients (API) Market: Orthopedics, 2018-2028, USD bn 93

Figure 53. Europe Active Pharmaceutical Ingredients (API) Market: Other Applications, 2018-2028, USD bn 94

Figure 54. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Drug Type, 2018-2028, % of Revenue 95

Figure 55. Contribution to Europe 2022-2028 Cumulative Revenue by Drug Type, Value (USD bn) and Share (%) 96

Figure 56. Europe Active Pharmaceutical Ingredients (API) Market: Branded Prescription Drugs, 2018-2028, USD bn 97

Figure 57. Europe Active Pharmaceutical Ingredients (API) Market: Generic Prescription Drugs, 2018-2028, USD bn 98

Figure 58. Europe Active Pharmaceutical Ingredients (API) Market: OTC Drugs, 2018-2028, USD bn 99

Figure 59. Breakdown of European Active Pharmaceutical Ingredients (API) Market by Country, 2021 and 2028, % of Revenue 101

Figure 60. Contribution to Europe 2022-2028 Cumulative Revenue by Country, Value (USD bn) and Share (%) 102

Figure 61. Active Pharmaceutical Ingredients (API) Market in UK, 2018-2028, USD bn 103

Figure 62. Active Pharmaceutical Ingredients (API) Market in France, 2018-2028, USD bn 105

Figure 63. Active Pharmaceutical Ingredients (API) Market in Germany, 2018-2028, USD bn 107

Figure 64. Active Pharmaceutical Ingredients (API) Market in Spain, 2018-2028, USD bn 109

Figure 65. Active Pharmaceutical Ingredients (API) Market in Italy, 2018-2028, USD bn 111

Figure 66. Active Pharmaceutical Ingredients (API) Market in Russia, 2018-2028, USD bn 113

Figure 67. Active Pharmaceutical Ingredients (API) Market in Rest of Europe, 2018-2028, USD bn 115

Figure 68. Growth Stage of Europe Active Pharmaceutical Ingredients (API) Industry over the Forecast Period 117

Figure 69. Top products of AstraZeneca based on revenue from 2016 to 2019 (in million U.S. dollars) 124


List Of Table

List of Tables:

Table 1. Snapshot of Europe Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2021-2028 19

Table 2. World Economic Outlook, 2021-2031 23

Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, USD bn 38

Table 4. Main Product Trends and Market Opportunities in Europe Active Pharmaceutical Ingredients (API) Market 42

Table 5. Europe Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, USD bn 50

Table 6. Europe Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2018-2028, USD bn 52

Table 7. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2018-2028, USD bn 56

Table 8. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2018-2028, USD bn 61

Table 9. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2018-2028, USD bn 64

Table 10. Europe Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2018-2028, USD bn 70

Table 11. Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, USD bn 73

Table 12. Europe Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2018-2028, USD bn 75

Table 13. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2018-2028, USD bn 79

Table 14. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2018-2028, USD bn 82

Table 15. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, USD bn 85

Table 16. Europe Active Pharmaceutical Ingredients (API) Market by Drug Type, 2018-2028, USD bn 95

Table 17. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2018-2028, USD bn 102

Table 18. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, USD bn 104

Table 19. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, USD bn 104

Table 20. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, USD bn 104

Table 21. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, USD bn 106

Table 22. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, USD bn 106

Table 23. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, USD bn 106

Table 24. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, USD bn 108

Table 25. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, USD bn 108

Table 26. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, USD bn 108

Table 27. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, USD bn 110

Table 28. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, USD bn 110

Table 29. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, USD bn 110

Table 30. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, USD bn 112

Table 31. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, USD bn 112

Table 32. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, USD bn 112

Table 33. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, USD bn 114

Table 34. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, USD bn 114

Table 35. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, USD bn 114

Table 36. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2018-2028, USD bn 116

Table 37. AbbVie Inc.: Company Snapshot 121

Table 38. AbbVie Inc.: Product Portfolio 121

Table 39. AbbVie Inc.: Revenue, 2018-2020, USD bn 122

Table 40. Astrazeneca: Company Snapshot 123

Table 41. Astrazeneca: Revenue, 2018-2020, USD bn 124

Table 42. Aurobindo Pharma Ltd.: Company Snapshot 128

Table 43. Aurobindo Pharma Ltd.: Product Portfolio 129

Table 44. BASF: Company Snapshot 131

Table 45. BASF: Business Segmentation 132

Table 46. BASF: Revenue by Region 132

Table 47. Bayer AG: Company Snapshot 134

Table 48. Bayer AG: Business Segmentation 135

Table 49. Bayer AG: Revenue, 2018-2020, EUR bn 135

Table 50. Boehringer Ingelheim: Company Snapshot 138

Table 51. Boehringer Ingelheim: Business Segmentation in 2019 139

Table 52. Boehringer Ingelheim: Product Portfolio 139

Table 53. Boehringer Ingelheim: Revenue, 2018-2020, EUR billion 140

Table 54. Boehringer Ingelheim: Revenue by Region in 2019 140

Table 55. Catalent Inc.: Company Snapshot 143

Table 56. Catalent Inc.: Business Segmentation in 2018 144

Table 57. Catalent Inc.: Product Portfolio 144

Table 58. Catalent Inc.: Revenue, 2018-2020, USD million 145

Table 59. Catalent Inc.: Revenue by Region in 2018 145

Table 60. Dr. Reddy's Laboratories: Company Snapshot 146

Table 61. Dr. Reddy's Laboratories: Business Segmentation 146

Table 62. Dr. Reddy's Laboratories: Revenue, 2019-2021, USD bn 147

Table 63. F. Hoffmann-La Roche: Company Snapshot 148

Table 64. F. Hoffmann-La Roche: Business Segmentation 149

Table 65. GlaxoSmithKline: Company Snapshot 150

Table 66. GlaxoSmithKline: Business Segmentation 151

Table 67. GlaxoSmithKline: Product Portfolio 152

Table 68. GlaxoSmithKline: Revenue, 2018-2020, USD bn 153

Table 69. Lonza Group: Company Snapshot 155

Table 70. Lonza Group: Business Segmentation in 2018 156

Table 71. Lonza Group: Product Portfolio 156

Table 72. Lonza Group: Revenue by Region in 2018 157

Table 73. Lupin Limited: Company Snapshot 160

Table 74. Lupin Limited: Business Segmentation 160

Table 75. Merck & Co., Inc.: Company Snapshot 163

Table 76. Merck & Co., Inc.: Business Segmentation 163

Table 77. Merck & Co., Inc.: Revenue, 2018-2020, USD bn 164

Table 78. Mylan NV: Company Snapshot 166

Table 79. Mylan NV: Revenue, 2017-2019, USD bn 167

Table 80. Novartis International AG: Company Snapshot 169

Table 81. Novartis International AG: Business Segmentation 169

Table 82. Novartis International AG: Revenue, 2017-2019, USD bn 170

Table 83. Pfizer Inc.: Company Snapshot 172

Table 84. Pfizer Inc.: Business Segmentation 173

Table 85. Pfizer Inc.: Product Portfolio 174

Table 86. Pfizer Inc.: Revenue, 2018-2020, USD bn 174

Table 87. Sanofi: Company Snapshot 177

Table 88. Sanofi: Business Segmentation 177

Table 89. Sanofi: Revenue, 2018-2020, USD bn 178

Table 90. Sun Pharmaceutical Industries Limited: Company Snapshot 180

Table 91. Teva Pharmaceutical Industries Ltd.: Company Snapshot 183

Table 92. Teva Pharmaceutical Industries Ltd.: Business Segmentation 184

Table 93. Thermo Fisher Scientific: Company Snapshot 185

Table 94. Risk Evaluation for Investing in Europe Market, 2021-2028 188

Table 95. Critical Success Factors and Key Takeaways 191

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

408564 Reports in repository
150+ Consulting project
100+ Analysts
8000+ Client Queries in 2022